Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04882111 · ClinicalTrials.gov registry record · Early Phase 1
ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF
A Early Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT04882111 is a Early Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 45 participants.
The verdict
NCT04882111, a Early Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a single arm, pre-post, pilot study assessing the feasibility and acceptability of the ALIGN intervention in metastatic adult cancer patients discharging to local area SNFs.
Interventions
- BEHAVIORAL ALIGN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2021-11-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04882111
The ClinicalTrials.gov registry entry for NCT04882111 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALIGN is the first listed.
NCT04882111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04882111 about?
NCT04882111 is a clinical study titled "ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF". This is a single arm, pre-post, pilot study assessing the feasibility and acceptability of the ALIGN intervention in metastatic adult cancer patients discharging to local area SNFs.
What is the current status of trial NCT04882111?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2020-09-28. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04882111?
The interventions under investigation include: ALIGN (BEHAVIORAL).
Who is sponsoring clinical trial NCT04882111?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.